Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica to Model Structures of GPCRs for Procter and Gamble Pharmaceuticals

NEW YORK, May 18 (GenomeWeb News) - Inpharmatica will develop computational structural models of families of human G-protein coupled receptors for Procter and Gamble Pharmaceuticals, the company said today.


Under the agreement, P&GP, a subsidiary of Procter and Gamble, will fund a research program at London-based Inpharmatica and will pay license fees for discoveries resulting from the project.


Inpharmatica will use its PharmaCarta platform to create computational structural models and to identify chemotypes for families of human G-protein coupled receptors.